Gary Y Yang

Summary

Affiliation: Roswell Park Cancer Institute
Country: USA

Publications

  1. ncbi request reprint Multimodality approaches for pancreatic cancer
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
    CA Cancer J Clin 55:352-67. 2005
  2. doi request reprint Renal atrophy secondary to chemoradiotherapy of abdominal malignancies
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
    Int J Radiat Oncol Biol Phys 78:539-46. 2010
  3. ncbi request reprint Long-term outcome of stage I seminoma
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Am J Clin Oncol 30:205-10. 2007
  4. ncbi request reprint Misrepresentation of publications among radiation oncology residency applicants
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    J Am Coll Radiol 3:259-64. 2006
  5. doi request reprint Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma
    Marwan G Fakih
    Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
    Int J Radiat Oncol Biol Phys 72:650-7. 2008
  6. doi request reprint Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen
    Kilian Salerno May
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Int J Radiat Oncol Biol Phys 76:1193-8. 2010
  7. pmc Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies
    Kilian Salerno May
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Gastrointest Oncol 1:7-15. 2010
  8. ncbi request reprint Palliation of malignant dysphagia in esophageal cancer: a literature-based review
    Milind Javle
    Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo, New York 14263, USA
    J Support Oncol 4:365-73, 379. 2006
  9. ncbi request reprint Cancer immunotherapy and heat-shock proteins: promises and challenges
    Masoud H Manjili
    Department of Cellular Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
    Expert Opin Biol Ther 4:363-73. 2004
  10. ncbi request reprint A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
    Marwan G Fakih
    Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Int J Radiat Oncol Biol Phys 65:1462-70. 2006

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Multimodality approaches for pancreatic cancer
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
    CA Cancer J Clin 55:352-67. 2005
    ..Our aim is to summarize the current state-of-the-art management and future directions regarding the multimodality approach to pancreatic cancer...
  2. doi request reprint Renal atrophy secondary to chemoradiotherapy of abdominal malignancies
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA
    Int J Radiat Oncol Biol Phys 78:539-46. 2010
    ..To identify factors predictive of renal atrophy after chemoradiotherapy of gastrointestinal malignancies...
  3. ncbi request reprint Long-term outcome of stage I seminoma
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Am J Clin Oncol 30:205-10. 2007
    ..To report on long-term outcomes among patients with stage I seminoma treated by orchiectomy with or without adjuvant radiation...
  4. ncbi request reprint Misrepresentation of publications among radiation oncology residency applicants
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    J Am Coll Radiol 3:259-64. 2006
    ..Authorship misrepresentations have been described for residency and fellowship applications for various medical specialties. This study assessed the prevalence of misrepresented publications in radiation oncology residency applications...
  5. doi request reprint Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma
    Marwan G Fakih
    Department of Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA
    Int J Radiat Oncol Biol Phys 72:650-7. 2008
    ..To evaluate the efficacy of a combination of capecitabine, oxaliplatin, and radiotherapy (RT) in the neoadjuvant treatment of Stage II and III rectal cancers...
  6. doi request reprint Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen
    Kilian Salerno May
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Int J Radiat Oncol Biol Phys 76:1193-8. 2010
    ..To analyze clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen...
  7. pmc Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies
    Kilian Salerno May
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Gastrointest Oncol 1:7-15. 2010
    ..This study evaluated the association between renal function as measured by biochemical endpoints and scintigraphy and dose volume parameters in patients with gastrointestinal malignancies...
  8. ncbi request reprint Palliation of malignant dysphagia in esophageal cancer: a literature-based review
    Milind Javle
    Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo, New York 14263, USA
    J Support Oncol 4:365-73, 379. 2006
    ..The benefits and disadvantages of these approaches along with a concise review of the literature are presented...
  9. ncbi request reprint Cancer immunotherapy and heat-shock proteins: promises and challenges
    Masoud H Manjili
    Department of Cellular Stress Biology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
    Expert Opin Biol Ther 4:363-73. 2004
    ..These points should also clarify the conflicting findings about HSPs and promote our knowledge about other immuologically important components that may be present in HSP preparations...
  10. ncbi request reprint A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma
    Marwan G Fakih
    Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Int J Radiat Oncol Biol Phys 65:1462-70. 2006
    ..We conducted a Phase I study to determine the maximum tolerated dose (MTD) of neoadjuvant capecitabine, oxaliplatin, and radiation therapy (RT) in Stage II to III rectal adenocarcinoma...
  11. doi request reprint The role of radiation in the perioperative treatment of esophagogastric cancer
    Kilian S May
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Curr Treat Options Oncol 12:61-71. 2011
    ..The current generation of clinical trials in this heterogeneous group of diseases is examining targeted therapy, newer methods of radiotherapy, and predictors of response to therapy aiming to tailor management to an individual patient...
  12. pmc The role of positron emission tomography in esophageal cancer
    Gary Y Yang
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York
    Gastrointest Cancer Res 2:3-9. 2008
    ..In addition, FDG-PET has also been shown to have prognostic value that can be applied to patient management and aid in development of emerging therapies...
  13. pmc FDG PET imaging in the staging and management of gastric cancer
    Shane Hopkins
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Gastrointest Oncol 2:39-44. 2011
    ..New criteria have been proposed establishing response metrics in the utilization of PET. More study is needed to support these criteria in routine practice and establish the place of PET in the staging and management of gastric cancer...
  14. pmc Benefits and challenges of radiation therapy in gastric cancer: techniques for improving outcomes
    Susan A McCloskey
    Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY
    Gastrointest Cancer Res 3:15-9. 2009
    ..The practicing clinician is urged to draw upon the multitude of resources now available to ensure that optimal RT for gastric cancer is delivered safely and accurately...
  15. pmc Positron emission tomography as predictor of rectal cancer response during or following neoadjuvant chemoradiation
    Shane Hopkins
    Shane Hopkins, Gary Y Yang, Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, United States
    World J Gastrointest Oncol 2:213-7. 2010
    ..Finding the best evaluation interval and parameters to use for interpreting PET results in the neo-adjuvant treatment of rectal cancer needs additional study...
  16. ncbi request reprint Cetuximab: its use in combination with radiation therapy and chemo-therapy in the multimodality treatment of head and neck cancer
    Timothy D Wagner
    Department of Radiology, Radiation Oncology Service, Brooke Army Medical Center, Fort Sam Houston, Texas, USA
    Recent Pat Anticancer Drug Discov 3:76-83. 2008
    ..In this manuscript, the mechanism of cetuximab with its associated patents is reviewed, with its role with chemotherapy and radiation in the management of head and neck cancer along with future directions of this targeted cancer therapy...
  17. ncbi request reprint Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer
    Sikander Ailawadhi
    Department of Internal Medicine, State University of New York at Buffalo, USA
    Oncology 70:49-53. 2006
    ..To investigate the incidence of carcinoembryonic antigen (CEA) surge in patients with metastatic colorectal cancer (MCRC) and its implications on clinical outcome...
  18. ncbi request reprint Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity
    Jerome C Landry
    Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
    Med Dosim 27:121-9. 2002
    ..IMRT with an inverse treatment plan has the potential to significantly improve radiation therapy of pancreatic cancers by reducing normal tissue dose, and simultaneously allow escalation of dose to further enhance locoregional control...